Pure Global AI
NCT06285929Enrolling by invitation

ACS Community Access to Resources Education and Support

Community Engagement in the Development of Oncology Navigation Training
American Cancer Society, Inc.ClinicalTrials.govother
Verified
Study focus
Disease/Condition
Neoplasms
Drug/Device/Intervention
ACS CARES Student Navigation
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
American Cancer Society, Inc.
Location
Los Angeles,Kennesaw,Iowa City,Charleston, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2023
End date
Dec 31, 2025
Enrollment
2000 participants
Primary outcome

Measure the impact of ACS CARES on patient-reported outcomes: SDOH barriers,Measure the impact of ACS CARES on patient-reported outcomes: Information Needs,Measure the impact of ACS CARES on patient-reported outcomes: Distress needs,Measure the impact of ACS CARES on patient-reported outcomes: Satisfaction with program,Measure the impact of ACS CARES on patient-reported outcomes: Unmet needs,Measure the impact of ACS CARES on patient-reported outcomes: Patient-provider communication,Measure the impact of ACS CARES on patient-reported outcomes: clinical trials knowledge,Measure the impact of ACS CARES on patient-reported outcomes: Patient activation,Measure the impact of ACS CARES on patient-reported outcomes: Financial toxicity,Measure the impact of ACS CARES on patient-reported outcomes: Quality of life,Context, Training, and Process Measures: Service Penetrance and Process Measures: Service Penetrance

Summary

The goal of this study is to evaluate the pilot phase of ACS Cares to identify key
 implementation outcomes and assess effectiveness of the program to improve distress, enhance
 communication, and reduce missed appointments and healthcare utilization.

ICD-10 classifications
NeoplasmsIn situ neoplasmsPersonal history of other neoplasmsBenign neoplasmsMalignant neoplasms
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06285929
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06285929 through Pure Global AI's free database. This phase not specified trial is sponsored by American Cancer Society, Inc. and is currently Enrolling by invitation. The study focuses on Neoplasms. Target enrollment is 2000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.